Skip to content
Open access

Common schizophrenia heritability concentrates in an evolutionarily young, brain-regulatory subset of fine-mapped credible-set variants

Jul 2026 · bioRxiv · 0 citations · 86 references
Biology

TL;DR

The persistence at common frequency of PGC3 schizophrenia common-variant heritability is most consistent with purifying selection and mutation-selection balance on these ancient, predominantly non-coding, brain-regulatory variants rather than recent adaptation.

Abstract

Common variation explains a substantial fraction of schizophrenia heritability, yet why these risk alleles persist remains unresolved. Of 20,766 fine-mapped PGC3 schizophrenia credible-set variants, the 4,918 with an allele-age estimate, brain-versus-blood regulatory specificity and a haplotype-based selection signal were clustered into three age-ordered subsets (Young, Mid and Old), all predating the out-of-Africa dispersal (cluster medians ≈113–508 kyr). The Young, brain-regulatory subset concentrated schizophrenia common-variant heritability after accounting for genome-wide allele age, frequency, linkage-disequilibrium and selection architecture (conditional coefficient Z = +3.05). The concentration generalized to East Asian schizophrenia (Z = +2.83), was balanced across sexes, and tracked genetic correlation across psychiatric disorders, including bipolar disorder, but not height or body-mass index. Their persistence at common frequency is most consistent with purifying selection and mutation-selection balance on these ancient, predominantly non-coding, brain-regulatory variants rather than recent adaptation.

Read PDF

Similar papers

Open access Sep 2026

Association of the Schizophrenia Risk Locus rs10866912 with Cerebral Volumes, Diet, and Psychosis in the UK Biobank

Background: Leading schizophrenia GWAS signals require evaluation of their pathological significance across diverse ancestries. rs10866912 reached genome-wide significance in our Indian ancestry GWAS of schizophrenia; its risk allele reduces expression of NAPRT, the rate-limiting enzyme in the brain’s principal NAD+-sy...

Lauren Jankowski, Sathish Periyasamy, P. Youssef et al. · 0 citations
#protein folding Open access Oct 2026

Rare coding variation implicates thirteen genes in bipolar disorder across 232,536 individuals from global populations

Bipolar disorder (BD) is highly heritable, yet the contribution of rare coding variation remains incompletely characterized. We analyzed sequencing data from 64,435 individuals with BD and 168,101 controls spanning multiple ancestries and 22 countries, representing the largest and most global sequencing resource with a...

C. Liao, R. Ye, J. Sealock et al. · 0 citations
Sep 2026

Developmental and cellular vulnerabilities underlie genetic architecture of schizophrenia.

A high-resolution cellular and temporal framework of SZ susceptibility is established, implicating mature associative IT microcircuits, deep-layer thalamocortical-regulating networks, and early developmental specification windows as primary points of genetic convergence in SZ.

Yong Wu, Yuan Gao, Miao Li et al. · 0 citations
Open access Sep 2026

Schizophrenia-associated polygenic liability and structural genomic risk demonstrate broadly distributed neuropsychiatric associations in the All of Us Research Program

Background: Schizophrenia liability reflects both the aggregate effects of many common genetic variants and rare structural variation at recurrent neurodevelopmental copy-number variant (ND-CNV) loci. Although both components of genetic liability have been associated with schizophrenia and related phenotypes, it remain...

Anne Marie Wells, An-Nie Dang, A. Ruiz · 0 citations
Open access Sep 2026

683. Genomic foundations of precision treatment: polygenic risk and pleiotropy in predicting therapeutic response

Abstract Background Major depressive disorder (MDD) is the most common mental disorder and is associated with substantial functional impairment, socioeconomic costs and reduced quality of life. One third of patients presents treatment-resistant depression (TRD), a major clinical challenge that highly contributes to the...

C. Pisanu, Y. Xiong, D. Congiu et al. · 0 citations
Open access Aug 2026

Genomic dimensions deconstruct the clinical heterogeneity of bipolar disorder

Bipolar disorder’s genetic architecture appears hierarchical—a general liability resolving into dimensions of course and comorbidity, beyond subtypes, beyond subtypes.

Tracey van der Veen, M. Tesfaye, J. M. K. Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.